评估尼日利亚改善婴儿及时乙型肝炎出生剂量疫苗接种和孕妇破伤风疫苗接种的干预措施
在尼日利亚阿达马瓦州和埃努古州80家公立卫生机构开展干预(卫生工作者与社区志愿者培训、孕妇参与、支持性督导),干预机构及时HepB-BD中位覆盖率从基线2.6%升至终期61.8%,Td2+从20.4%升至26.9%(p<0.05);对照机构终期及时HepB-BD为7.9%(p<0.0001),Td2+为22.2%(p=0.14)。
要点
- 干预机构及时HepB-BD中位覆盖率从基线2.6%升至终期61.8%(p<0.05)。
- 干预机构Td2+中位覆盖率从基线20.4%升至终期26.9%(p<0.05)。
- 对照机构终期及时HepB-BD为7.9%(p<0.0001),Td2+为22.2%(p=0.14)。
核心结论
- 针对性干预显著提高了干预机构及时HepB-BD和Td疫苗接种率。
- 持续支持这些成功干预可能帮助尼日利亚实现乙型肝炎和孕产妇及新生儿破伤风消除目标。
研究设计与样本
- 在阿达马瓦州和埃努古州选取80家公立卫生机构,一半为干预机构、一半为对照。
- 干预包括卫生工作者和社区志愿者培训、孕妇参与及机构内支持性督导。
- 在项目执行前基线(2021年1月至6月)和执行一年后终期(2022年1月至6月)评估及时HepB-BD覆盖率和至少两剂Td(Td2+)覆盖率。
- 在干预机构开展焦点小组讨论,讨论干预优势、挑战和改进机会。
主要发现
- 与基线相比,干预机构终期及时HepB-BD中位疫苗接种覆盖率从2.6%升至61.8%,Td2+从20.4%升至26.9%(p<0.05)。
- 对照机构终期及时HepB-BD中位疫苗接种覆盖率为7.9%(p<0.0001),Td2+覆盖率为22.2%(p=0.14)。
- 焦点小组讨论显示,卫生工作者因对乙型肝炎和破伤风知识增加而感到有能力接种疫苗。
- 孕妇知识增加,导致包括Td疫苗接种在内的就医行为改善。
- 需要交通支持以覆盖偏远社区人群。
临床怎么用
- 作者认为,持续支持这些成功干预可能帮助尼日利亚实现乙型肝炎和孕产妇及新生儿破伤风消除目标。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nigeria has the largest number of children infected with hepatitis B virus (HBV) globally and has not yet achieved maternal and neonatal tetanus elimination. In Nigeria, maternal tetanus diphtheria (Td) vaccination is part of antenatal care and hepatitis B birth dose (HepB-BD) vaccination for newborns has been offered since 2004. We implemented interventions targeting healthcare workers (HCWs), community volunteers, and pregnant women attending antenatal care with the goal of improving timely (within 24 hours) HepB-BD vaccination among newborns and Td vaccination coverage among pregnant women. METHODS: We selected 80 public health facilities in Adamawa and Enugu states, with half intervention facilities and half control. Interventions included HCW and community volunteer trainings, engagement of pregnant women, and supportive supervision at facilities. Timely HepB-BD coverage and at least two doses of Td (Td2+) coverage were assessed at baseline before project implementation (January-June 2021) and at endline, one year after implementation (January-June 2022). We held focus group discussions at intervention facilities to discuss intervention strengths, challenges, and improvement opportunities. RESULTS: Compared to baseline, endline median vaccination coverage increased for timely HepB-BD from 2.6% to 61.8% and for Td2+ from 20.4% to 26.9% in intervention facilities (p < 0.05). In comparison, at endline in control facilities median vaccination coverage for timely HepB-BD was 7.9% (p < 0.0001) and Td2+ coverage was 22.2% (p = 0.14). Focus group discussions revealed that HCWs felt empowered to administer vaccination due to increased knowledge on hepatitis B and tetanus, pregnant women had increased knowledge that led to improved health seeking behaviors including Td vaccination, and transportation support was needed to reach those in far communities. CONCLUSION: Targeted interventions significantly increased timely HepB-BD and Td vaccination rates in intervention facilities. Continued support of these successful interventions could help Nigeria reach hepatitis B and maternal and neonatal tetanus elimination goals.
引用
- Kanu FA, Freeland C, Nwokoro UU, et al. Evaluation of interventions to improve timely hepatitis B birth dose vaccination among infants and maternal tetanus vaccination among pregnant women in Nigeria. Vaccine. 2024. PMID: 39197221. doi:10.1016/j.vaccine.2024.126222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。